Disseminated Intravascular Coagulation (DIC) Global Market Report 2025
상품코드:1826916
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
파종성 혈관 내 응고(DIC) 시장 규모는 최근 꾸준히 성장하고 있습니다. 2024년 4억 6,000만 달러에서 2025년에는 4억 9,000만 달러에 달하고, CAGR 5.0%를 나타낼 전망입니다. 실적기간의 성장은 패혈증 유병률 상승, 외상증례 증가, 암 이환율 상승, 헬스케어 지출 증가, 헬스케어 전문가의 의식 향상, 표적요법 채용 증가에 기인하고 있습니다.
파종성 혈관 내 응고(DIC) 시장 규모는 향후 수년간 안정된 성장이 예상됩니다. 2029년에는 CAGR 4.9%를 나타내 5억 9,000만 달러로 성장할 전망입니다. 예측기간의 성장은 표적 치료의 채용 증가, 질병의 조기 발견에 대한 주목 증가, 헬스케어 인프라에 대한 투자 증가, 응고 이상증 치료에 관한 임상 연구의 확대, 희소 혈액 질환에 대한 의식 증가 등에 기인한다고 생각됩니다. 예측 기간의 주요 동향은 진단 분석 개선, 새로운 항응고 요법 채택, 개인화된 의료 접근법, 진단에서 AI 통합, 환자 모니터링 기술 강화, 표적 치료 개발 등을 포함합니다.
파종성 혈관 내 응고(DIC)은 혈액 응고 인자와 혈소판의 고갈로 인해 궁극적으로 심각한 출혈로 이어지는 과도한 혈액 응고를 특징으로 하는 심각한 생명을 위협하는 질병입니다. 패혈증, 외상, 악성 종양, 산과 합병증 등의 기본 질환으로 인해 발생합니다.
파종성 혈관 내 응고(DIC)의 주요 치료법은 약물 요법, 수혈, 수술 및 기타 치료법을 포함합니다. 약물 요법에는 DIC와 관련된 응고 및 출혈성 합병증의 관리를 목적으로 하는 항응고제, 혈액 제제 및 지지제가 포함됩니다. 진단 방법에는 혈액 도말 검사를 통한 전혈구 산정, 부분 트롬보플라스틴 시간(PTT), 피브리노겐 혈액 검사, D-다이머 검사 및 기타 진단 절차가 포함됩니다. 이러한 검사는 경구, 비경구, 대체법 등 다양한 경로로 실시되며, 병원 약국, 소매 약국, 온라인 약국을 통해 유통되고 있습니다. 치료 옵션은 병원, 전문 클리닉, 홈 케어 환경 및 기타 건강 관리 시설에서 사용됩니다.
2025년 봄 미국 관세의 급상승과 이에 따른 무역 마찰은 건강 관리 부문, 특히 필수 의료기기, 진단 장비 및 의약품 공급에 큰 영향을 미쳤습니다. 병원과 건강 관리 제공업체는 수입되는 수술 기구, 영상 진단 시스템, 주사기 및 카테터와 같은 소모품의 비용 상승에 시달리고 있으며, 그 대부분은 국내 대체품이 제한되어 있습니다. 이러한 비용 상승이 의료 예산을 압박하기 때문에 일부 의료기관은 장비 업그레이드를 늦추거나 비용 증가를 환자에게 전가하고 있습니다. 게다가 원료와 부품에 대한 관세는 중요한 의약품과 의료기기의 제조에 지장을 주고 공급망의 지연으로 이어지고 있습니다. 이에 비해 업계는 다양한 조달 전략을 채택하고 가능한 한 현지 생산을 확대하고 중요한 의료 제품의 관세 면제를 수행하고 있습니다.
이 조사 보고서는 파종성 혈관 내 응고(DIC) 산업 세계 시장 규모, 지역 점유율, 파종성 혈관 내 응고(DIC) 시장 점유율을 가진 경쟁업체, 상세한 파종성 혈관 내 응고(D IC) 시장 부문, 시장 동향 및 비즈니스 기회, 파종성 혈관 내 응고(DIC) 업계에서 성공하는 데 필요한 데이터 등 파종성 혈관 내 응고(DIC) 시장 통계를 제공하는 The Business Research Company의 신간 보고서 시리즈 중 하나입니다. 이 파종성 혈관 내 응고(DIC) 시장 조사 보고서는 업계의 현재 및 미래 시나리오를 자세히 분석하고 필요한 모든 것을 완벽한 관점에서 제공합니다.
향후 5년간의 성장률 4.9%라고 하는 예측은 전회 예측으로부터 0.1%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세의 부과는 오스트리아와 벨기에에서 조달하는 유전자 재조합 인자 VIIa 제형 및 안티트롬빈 제형의 비용을 증가시키고 패혈증 환자의 구명 치료를 지연시킬 수 있기 때문에 미국 병원에 심각한 과제를 초래할 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.
암 이환율의 상승이 파종성 혈관 내 응고(DIC) 시장 성장을 견인할 것으로 예측됩니다. 암은 정상 조직에 침입하여 손상을 주는 이상 세포의 무질서한 증식과 확산을 특징으로 하는 질환입니다. 암 환자 증가는 고령화, 라이프 스타일의 변화, 환경 노출, 감염증, 유전적 소인 등의 요인에 기인하고 있습니다. 암은 종양이 생산하는 응고 촉진 물질에 의해 응고 캐스케이드를 과도하게 활성화시켜 광범위하게 응고와 출혈을 초래함으로써 파종성 혈관 내 응고(DIC)를 일으킬 수 있습니다. 예를 들어 2024년 5월 미국 정부기관인 국립암연구소는 2022년 세계에서 약 2,000만명의 신규암 환자와 970만명의 암 관련 사망이 기록되었다고 보고했습니다. 예측에서 이 수치는 2040년까지 연간 2,990만 명의 신규 이환 환자와 1,530만 명의 사망자로 증가할 것으로 추정됩니다. 그 결과, 암 유병률 증가가 파종성 혈관 내 응고(DIC) 시장 성장을 뒷받침하고 있습니다.
파종성 혈관 내 응고(DIC) 시장 주요 기업은 차세대 혈액 응고 검사 등의 응고 진단 기술을 진보시켜 진단 정밀도, 속도, 편리성을 향상시키고 있습니다. 이러한 혁신은 적시에 개입을 가능하게 하고 환자의 결과를 향상시킵니다. 차세대 혈액 응고 검사는 기존 방법보다 정확하고 효율적이며 종합적으로 혈액 응고를 평가하도록 고안된 고급 진단 도구입니다. 예를 들어, 2022년 6월 영국의 건강 관리 기업인 Lumiladex Limited는 NT-proBNP 및 업데이트 D-이량체 검사에 대한 CE 마크 승인을 받았으며 심혈관 검사 포트폴리오를 확장했습니다. 이러한 향상으로 루미라덱스 플랫폼은 심부전 진단과 정맥 혈전 색전증을 제외한 요점을 근거로 임상가를 지원하는 능력을 강화합니다. 이러한 개선은 파종성 혈관 내 응고(DIC)를 포함한 심혈관계 및 혈전성 질환의 조기 발견 및 관리를 개선하는 것을 목적으로 합니다.
2024년 3월 중국 생명공학 기업인 MediLink Therapeutics(Suzhou) Co., Ltd.는 파종성 혈관 내 응고(DIC)를 포함한 혈전 질환의 치료제로 YL201을 평가하기 위해 Amgen Inc.와 제휴를 체결했습니다. 이 제휴는 혈액 응고 요법을 발전시키고 치료 효과와 환자 결과를 개선하는 것을 목표로 합니다. 암젠은 미국을 기반으로 하는 바이오 의약품 기업으로 혁신적인 치료제의 발견, 개발, 제조에 특화되어 있습니다.
파종성 혈관 내 응고(DIC) 시장은 의약품 치료, 항응고 치료, 진단 서비스, 치명적인 케어 개입 등의 서비스를 제공하는 기업이 얻는 수익으로 구성되어 있습니다. 시장 가치에는 서비스 제공업체가 판매하거나 서비스 제공에 포함된 관련 상품의 가치도 포함됩니다. 파종성 혈관 내 응고(DIC) 시장에는 진단 도구, 항응고제, 혈소판, 신선한 동결 혈장, 동결 침전물 등의 혈액 제제의 판매도 포함됩니다. 이 시장의 가치는 "Factory Gate"가치, 즉 다른 기업(다운스트림 제조업자, 도매업체, 유통업체, 소매업체 포함)이든 직접 최종 고객이든, 상품 제조자 또는 제조자가 판매한 상품의 가치입니다. 이 시장에서 상품의 가치에는 상품 제작자에 의해 판매되는 관련 서비스도 포함됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 파종성 혈관 내 응고(DIC) : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 파종성 혈관 내 응고(DIC) 시장 : 성장률 분석
세계의 파종성 혈관 내 응고(DIC) 시장 실적 : 규모와 성장(2019-2024년)
세계의 파종성 혈관 내 응고(DIC) 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 파종성 혈관 내 응고(DIC) : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 파종성 혈관 내 응고(DIC) 시장 : 치료별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
의약품
수혈
수술
기타 치료법
세계의 파종성 혈관 내 응고(DIC) 시장 : 진단별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
혈액 도말 검사를 포함한 완전 혈구 계수
부분 트롬보플라스틴 시간(PTT)
피브리노겐 혈액 검사
D 다이머
기타 진단
세계의 파종성 혈관 내 응고(DIC) 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구
비경구
기타 투여 경로
세계의 파종성 혈관 내 응고(DIC) 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원 약국
소매 약국
온라인 약국
세계의 파종성 혈관 내 응고(DIC) 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
전문 클리닉
홈케어
기타 최종 사용자
세계의 파종성 혈관 내 응고(DIC) 시장 : 의약품 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
항응고제
항혈소판제
섬유소용해제
응고촉진제
항트롬빈 치료제
세계의 파종성 혈관 내 응고(DIC) 시장 : 수혈 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
혈소판 수혈
신선 냉동 혈장(FFP)
냉동응고물 수혈
적혈구 수혈
세계의 파종성 혈관 내 응고(DIC) 시장 : 수술 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
혈전 수술적 제거
장기 수술
세계의 파종성 혈관 내 응고(DIC) 시장 : 기타 치료법 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
혈장 교환
지지적 치료
스테로이드 요법
제7장 지역별/국가별 분석
세계의 파종성 혈관 내 응고(DIC) 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 파종성 혈관 내 응고(DIC) 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
파종성 혈관 내 응고(DIC) 시장 : 경쟁 구도
파종성 혈관 내 응고(DIC) 시장 : 기업 프로파일
Nihon Kohden Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Johnson & Johnson : 개요, 제품 및 서비스, 전략 및 재무 분석
F. Hoffmann-La Roche Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Merck & Co.Inc.
Bayer AG
Sanofi SA
AstraZeneca plc
Abbott Laboratories
Novartis AG
Thermo Fisher Scientific Inc.
Fresenius Kabi AG
GlaxoSmithKline plc
Danaher Corporation
Eli Lily and Company
Siemens Healthineers
Teva Pharmaceutical Industries Ltd.
Mylan NV
Grifols SA
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
파종성 혈관 내 응고(DIC) 시장(2029년) : 새로운 기회를 제공하는 국가
파종성 혈관 내 응고(DIC) 시장(2029년) : 새로운 기회를 제공하는 부문
파종성 혈관 내 응고(DIC) 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
KTH
영문 목차
영문목차
Disseminated intravascular coagulation (DIC) is a severe, life-threatening condition marked by excessive blood clotting, which eventually leads to significant bleeding due to the depletion of clotting factors and platelets. It is triggered by underlying conditions such as sepsis, trauma, malignancies, and obstetric complications.
The primary treatments for disseminated intravascular coagulation (DIC) include medications, transfusions, surgery, and other therapeutic approaches. Medications consist of anticoagulants, blood products, and supportive drugs aimed at managing clotting and bleeding complications related to DIC. Diagnostic methods include a complete blood count with blood smear examination, partial thromboplastin time (PTT), fibrinogen blood test, D-dimer test, and other diagnostic procedures. These tests are administered through various routes, such as oral, parenteral, and alternative methods, and are distributed through hospital pharmacies, retail pharmacies, and online pharmacies. Treatment options are utilized across hospitals, specialty clinics, homecare settings, and other healthcare facilities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The disseminated intravascular coagulation (DIC) market research report is one of a series of new reports from The Business Research Company that provides disseminated intravascular coagulation (DIC) market statistics, including the disseminated intravascular coagulation (DIC) industry's global market size, regional shares, competitors with a disseminated intravascular coagulation (DIC) market share, detailed disseminated intravascular coagulation (DIC) market segments, market trends and opportunities, and any further data you may need to thrive in the disseminated intravascular coagulation (DIC) industry. This disseminated intravascular coagulation (DIC) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The disseminated intravascular coagulation (dic) market size has grown steadily in recent years. It will grow from $0.46 billion in 2024 to $0.49 billion in 2025 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to rise in prevalence of sepsis, increase in trauma cases, growth in cancer incidence, higher healthcare spending, enhanced awareness among healthcare professionals, and rise in adoption of targeted therapies.
The disseminated intravascular coagulation (dic) market size is expected to see steady growth in the next few years. It will grow to $0.59 billion in 2029 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to increasing adoption of targeted therapies, growing focus on early disease detection, rising investments in healthcare infrastructure, expansion of clinical research on coagulopathy treatments, and heightened awareness of rare hematological conditions. Major trends in the forecast period include improved diagnostic assays, adoption of novel anticoagulant therapies, personalized medicine approaches, integration of AI in diagnostics, enhanced patient monitoring technologies, and development of targeted treatments.
The forecast of 4.9% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose critical challenges for U.S. hospitals by increasing costs for recombinant factor VIIa and antithrombin concentrates sourced from Austria and Belgium, potentially delaying life-saving interventions for septic patients. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising incidence of cancer is expected to drive the growth of the disseminated intravascular coagulation (DIC) market. Cancer is a disease characterized by the uncontrolled proliferation and spread of abnormal cells, which can invade and damage normal tissues. The increasing number of cancer cases is attributed to factors such as an aging population, lifestyle changes, environmental exposure, infections, and genetic predisposition. Cancer can lead to disseminated intravascular coagulation (DIC) by excessively activating the coagulation cascade through tumor-produced procoagulant substances, resulting in widespread clotting and bleeding. For example, in May 2024, the National Cancer Institute, a US-based government agency, reported that in 2022, approximately 20 million new cancer cases and 9.7 million cancer-related deaths were recorded globally. Projections indicate that these figures could rise to 29.9 million new cases and 15.3 million deaths annually by 2040. As a result, the increasing prevalence of cancer is fueling the growth of the disseminated intravascular coagulation (DIC) market.
Leading companies in the disseminated intravascular coagulation (DIC) market are advancing coagulation diagnostic technologies, such as next-generation blood clotting tests, to improve diagnostic accuracy, speed, and convenience. These innovations enable timely intervention and enhance patient outcomes. Next-generation blood clotting tests are advanced diagnostic tools designed to assess blood coagulation more precisely, efficiently, and comprehensively than traditional methods. For instance, in June 2022, LumiraDx Limited, a UK-based healthcare company, expanded its cardiovascular testing portfolio by obtaining CE Mark approvals for its NT-proBNP and updated D-Dimer tests. These enhancements strengthen the LumiraDx Platform's ability to assist clinicians in diagnosing heart failure and ruling out venous thromboembolism at the point of care. Such advancements aim to improve the early detection and management of cardiovascular and thrombotic conditions, including disseminated intravascular coagulation (DIC).
In March 2024, MediLink Therapeutics (Suzhou) Co. Ltd., a China-based biotech company, entered into a collaboration with Amgen Inc. to evaluate YL201 for the treatment of thrombotic disorders, including disseminated intravascular coagulation (DIC). This partnership seeks to advance blood clotting therapies, improving treatment effectiveness and patient outcomes. Amgen Inc. is a US-based biopharmaceutical company specializing in the discovery, development, and manufacturing of innovative therapeutics.
Major players in the disseminated intravascular coagulation (DIC) market are Nihon Kohden Corporation, Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., AbbVie Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, Thermo Fisher Scientific Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Danaher Corporation, Eli Lily and Company, Siemens Healthineers, Teva Pharmaceutical Industries Ltd., Mylan N.V., Grifols S.A., Eisai Co. Ltd., Beckman Coulter Inc., Sysmex Corporation, and Bio-Rad Laboratories Inc.
North America was the largest region in the disseminated intravascular coagulation (DIC) market in 2024. The regions covered in disseminated intravascular coagulation (DIC) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the disseminated intravascular coagulation (DIC) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The disseminated intravascular coagulation (DIC) market consists of revenues earned by entities by providing services such as pharmaceutical treatments, anticoagulant therapies, diagnostic services, and critical care interventions. The market value includes the value of related goods sold by the service provider or included within the service offering. The disseminated intravascular coagulation (DIC) market also includes sales of diagnostic tools, anticoagulant medications, and blood products such as platelets, fresh frozen plasma, or cryoprecipitate. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Disseminated Intravascular Coagulation (DIC) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on disseminated intravascular coagulation (dic) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for disseminated intravascular coagulation (dic) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The disseminated intravascular coagulation (dic) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Treatment: Medicines; Transfusions; Surgery; Other Treatments
2) By Diagnosis: Complete Blood Count With Blood Smear Exam; Partial Thromboplastin Time (PTT); Fibrinogen Blood Test; D-dimer; Other Diagnoses
3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
Subsegments:
1) By Medicines: Anticoagulants; Antiplatelet Drugs; Fibrinolytics; Procoagulants; Antithrombin Therapy
2) By Transfusions: Platelet Transfusion; Fresh Frozen Plasma (FFP); Cryoprecipitate Transfusion; Red Blood Cell Transfusion
3) By Surgery: Surgical Removal Of Thrombus; Organ Surgery
4) By Other Treatments: Plasma Exchange; Supportive Care; Steroid Therapy
Companies Mentioned: Nihon Kohden Corporation; Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Merck & Co. Inc.; Bayer AG; Sanofi S.A.; AstraZeneca plc; Abbott Laboratories; Novartis AG; Thermo Fisher Scientific Inc.; Fresenius Kabi AG; GlaxoSmithKline plc; Danaher Corporation; Eli Lily and Company; Siemens Healthineers; Teva Pharmaceutical Industries Ltd.; Mylan N.V.; Grifols S.A.; Eisai Co. Ltd.; Beckman Coulter Inc.; Sysmex Corporation; Bio-Rad Laboratories Inc.
3. Disseminated Intravascular Coagulation (DIC) Market Trends And Strategies
4. Disseminated Intravascular Coagulation (DIC) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Disseminated Intravascular Coagulation (DIC) Growth Analysis And Strategic Analysis Framework
5.1. Global Disseminated Intravascular Coagulation (DIC) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Disseminated Intravascular Coagulation (DIC) Market Growth Rate Analysis
5.4. Global Disseminated Intravascular Coagulation (DIC) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Disseminated Intravascular Coagulation (DIC) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Disseminated Intravascular Coagulation (DIC) Total Addressable Market (TAM)
6.1. Global Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medicines
Transfusions
Surgery
Other Treatments
6.2. Global Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Complete Blood Count with Blood Smear Exam
Partial Thromboplastin Time (PTT)
Fibrinogen Blood Test
D-dimer
Other Diagnoses
6.3. Global Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
Other Routes Of Administration
6.4. Global Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
6.5. Global Disseminated Intravascular Coagulation (DIC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Homecare
Other End-Users
6.6. Global Disseminated Intravascular Coagulation (DIC) Market, Sub-Segmentation Of Medicines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Anticoagulants
Antiplatelet Drugs
Fibrinolytics
Procoagulants
Antithrombin Therapy
6.7. Global Disseminated Intravascular Coagulation (DIC) Market, Sub-Segmentation Of Transfusions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Platelet Transfusion
Fresh Frozen Plasma (FFP)
Cryoprecipitate Transfusion
Red Blood Cell Transfusion
6.8. Global Disseminated Intravascular Coagulation (DIC) Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Surgical Removal Of Thrombus
Organ Surgery
6.9. Global Disseminated Intravascular Coagulation (DIC) Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Plasma Exchange
Supportive Care
Steroid Therapy
7. Disseminated Intravascular Coagulation (DIC) Market Regional And Country Analysis
7.1. Global Disseminated Intravascular Coagulation (DIC) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Disseminated Intravascular Coagulation (DIC) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Disseminated Intravascular Coagulation (DIC) Market
9.1. China Disseminated Intravascular Coagulation (DIC) Market Overview
9.2. China Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Disseminated Intravascular Coagulation (DIC) Market
10.1. India Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Disseminated Intravascular Coagulation (DIC) Market
11.1. Japan Disseminated Intravascular Coagulation (DIC) Market Overview
11.2. Japan Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Disseminated Intravascular Coagulation (DIC) Market
12.1. Australia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Disseminated Intravascular Coagulation (DIC) Market
13.1. Indonesia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Disseminated Intravascular Coagulation (DIC) Market
14.1. South Korea Disseminated Intravascular Coagulation (DIC) Market Overview
14.2. South Korea Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Disseminated Intravascular Coagulation (DIC) Market
15.1. Western Europe Disseminated Intravascular Coagulation (DIC) Market Overview
15.2. Western Europe Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Disseminated Intravascular Coagulation (DIC) Market
16.1. UK Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.1. Germany Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Disseminated Intravascular Coagulation (DIC) Market
18.1. France Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.1. Spain Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Disseminated Intravascular Coagulation (DIC) Market
21.1. Eastern Europe Disseminated Intravascular Coagulation (DIC) Market Overview
21.2. Eastern Europe Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Disseminated Intravascular Coagulation (DIC) Market
22.1. Russia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Disseminated Intravascular Coagulation (DIC) Market
23.1. North America Disseminated Intravascular Coagulation (DIC) Market Overview
23.2. North America Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Disseminated Intravascular Coagulation (DIC) Market
24.1. USA Disseminated Intravascular Coagulation (DIC) Market Overview
24.2. USA Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Disseminated Intravascular Coagulation (DIC) Market
26.1. South America Disseminated Intravascular Coagulation (DIC) Market Overview
26.2. South America Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Disseminated Intravascular Coagulation (DIC) Market
27.1. Brazil Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Disseminated Intravascular Coagulation (DIC) Market
28.1. Middle East Disseminated Intravascular Coagulation (DIC) Market Overview
28.2. Middle East Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Disseminated Intravascular Coagulation (DIC) Market
29.1. Africa Disseminated Intravascular Coagulation (DIC) Market Overview
29.2. Africa Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Disseminated Intravascular Coagulation (DIC) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Disseminated Intravascular Coagulation (DIC) Market Competitive Landscape And Company Profiles
